128 related articles for article (PubMed ID: 16610311)
41. Reactive oxygen metabolites as an index of chronic obstructive pulmonary disease severity.
Markoulis N; Gourgoulianis KI; Moulas A; Gerogianni E; Molyvdas AP
Panminerva Med; 2006 Dec; 48(4):209-13. PubMed ID: 17215792
[TBL] [Abstract][Full Text] [Related]
42. Clinical value of anthropometric estimates of leg lean volume in nutritionally depleted and non-depleted patients with chronic obstructive pulmonary disease.
Villaça DS; Lerario MC; dal Corso S; Nápolis L; de Albuquerque AL; Lazaretti-Castro M; Sachs A; Nery LE; Neder JA
Br J Nutr; 2008 Aug; 100(2):380-6. PubMed ID: 18184453
[TBL] [Abstract][Full Text] [Related]
43. [Impaired lung function in patients with moderate chronic obstructive bronchitis].
Nefedov VB; Popova LA; Shergina EA
Probl Tuberk Bolezn Legk; 2004; (12):41-4. PubMed ID: 15719666
[TBL] [Abstract][Full Text] [Related]
44. [Early stages and development of chronic obstructive pneumopathy].
Stănescu LD
Bull Mem Acad R Med Belg; 1990; 145(3-4):200-5; discussion 205-8. PubMed ID: 2207462
[TBL] [Abstract][Full Text] [Related]
45. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.
Pauwels RA; Buist AS; Ma P; Jenkins CR; Hurd SS;
Respir Care; 2001 Aug; 46(8):798-825. PubMed ID: 11463370
[No Abstract] [Full Text] [Related]
46. [Lung dysfunction in patients with severe chronic obstructive bronchitis].
Nefedov VB; Popova LA; Shergina EA
Probl Tuberk Bolezn Legk; 2005; (4):11-4. PubMed ID: 15938497
[TBL] [Abstract][Full Text] [Related]
47. Nosology for our day: its application to chronic obstructive pulmonary disease.
Snider GL
Am J Respir Crit Care Med; 2003 Mar; 167(5):678-83. PubMed ID: 12598211
[No Abstract] [Full Text] [Related]
48. Predicting outcomes in chronic obstructive pulmonary disease.
Garcia-Pachon E; Padilla-Nava I
N Engl J Med; 2004 May; 350(22):2308-10; author reply 2308-10. PubMed ID: 15163786
[No Abstract] [Full Text] [Related]
49. What is the role of tests of lung function in the management of infants with lung disease?
Godfrey S; Bar-Yishay E; Avital A; Springer C
Pediatr Pulmonol; 2003 Jul; 36(1):1-9. PubMed ID: 12772216
[TBL] [Abstract][Full Text] [Related]
50. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.
Quanjer PH; Tammeling GJ; Cotes JE; Pedersen OF; Peslin R; Yernault JC
Eur Respir J Suppl; 1993 Mar; 16():5-40. PubMed ID: 8499054
[No Abstract] [Full Text] [Related]
51. Heart failure and chronic obstructive pulmonary disease: lung function test interpretation.
van Helvoort HA; Heijdra YF
Eur J Heart Fail; 2009 Jun; 11(6):632; author reply 632-3. PubMed ID: 19414478
[No Abstract] [Full Text] [Related]
52. [Exacerbation in chronic obstructive lung disease--better prevention and treatment. The Danish Society of Pulmonary Medicine].
Vestbo J; Ulrik CS
Ugeskr Laeger; 2003 Mar; 165(12):1243. PubMed ID: 12701293
[No Abstract] [Full Text] [Related]
53. [Implication of the lung function tests in chronic obstructive pulmonary disease].
Satinská J
Vnitr Lek; 2004 Sep; 50(9):670-4. PubMed ID: 15580899
[TBL] [Abstract][Full Text] [Related]
54. [A missing link in classification of occupational pulmonary diseases--occupational chronic obstructive lung diseases].
Zinchenko VA; Razumov VV; Gurevich EB
Med Tr Prom Ekol; 2004; (6):33-4. PubMed ID: 15318456
[TBL] [Abstract][Full Text] [Related]
55. Defining chronic obstructive pulmonary disease... and the elephant in the room.
Mannino DM
Eur Respir J; 2007 Aug; 30(2):189-90. PubMed ID: 17666553
[No Abstract] [Full Text] [Related]
56. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.
Sterk PJ; Fabbri LM; Quanjer PH; Cockcroft DW; O'Byrne PM; Anderson SD; Juniper EF; Malo JL
Eur Respir J Suppl; 1993 Mar; 16():53-83. PubMed ID: 8499055
[No Abstract] [Full Text] [Related]
57. Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease.
Scarlata S; Conte ME; Cesari M; Gentilucci UV; Miglioresi L; Pedone C; Picardi A; Ricci GL; Incalzi RA
Liver Int; 2011 Apr; 31(4):525-33. PubMed ID: 21382163
[TBL] [Abstract][Full Text] [Related]
58. The GOLD classification has advanced understanding of COPD.
Calverley PM
Am J Respir Crit Care Med; 2004 Aug; 170(3):211-2; discussion 214. PubMed ID: 15280171
[No Abstract] [Full Text] [Related]
59. [New trends in the classification, diagnostics, and treatment of chronic obstructive pulmonary diseases].
Leshchenko IV
Ter Arkh; 2004; 76(3):77-80. PubMed ID: 15108467
[No Abstract] [Full Text] [Related]
60. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice.
;
Am J Respir Crit Care Med; 2005 Dec; 172(11):1463-71. PubMed ID: 16301301
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
